Cyprotex specializes in ADME-Tox and Biosciences including both in vitro (laboratory experiments) and in silico (computer modeling) approaches.
Cyprotex was founded in 1999, and in 2002 it was listed on the London Stock Exchange’s AIM Market (symbol CRX, information for investors).
Our headquarters are in Macclesfield, UK, near Manchester, but we also have laboratories in Watertown, MA and Kalamazoo, MI in the USA.
313 Pleasant St.
02472 United States